Results Eighty-five patients completed the trial, of whom 43 were in the PCT group and 42
were in the control group. The PCT group had a significantly lower mean (SD) antibiotic …

Purpose Ventilator-associated pneumonia (VAP) increases exposure to antibiotics.
Physicians are however reluctant to shorten treatment, arguing this could lead to failures …

In patients with ventilator-associated pneumonia (VAP), guidelines recommend antibiotic
therapy adjustment according to microbiology results after 72 h. Circulating procalcitonin …

Background Procalcitonin (PCT), an important biomarker, can be used for the guidance of
antibiotic therapy in respiratory infection. However, it has been a problem that some patients …

Procalcitonin's contribution to the diagnosis of nosocomial infection, particularly ventilator-
associated pneumonia (VAP), is poor: its levels in patients with microbiologically …

Background Ventilator-associated pneumonia (VAP) is one of the most common nosocomial
infection, associated with considerable mortality and morbidity in critically ill patients; …

Ventilator-associated pneumonia (VAP) continues to be a major problem in the care of
intensive care unit (ICU) patients. The incidence of VAP in mechanically ventilated patients …

Previous studies demonstrated the efficacy of procalcitonin (Pct) blood levels guiding
antibiotic treatment in respiratory infections. We set out to de–termine whether early …

Background We wanted to determine the impact of combined Clinical Pulmonary Infection
Score (CPIS) and a spot serum procalcitonin (PCT)-guided protocol to shorten the duration …

Objective To assess the predictive capacity for the diagnosis of ventilator-associated
pneumonia (VAP) of serum procalcitonin levels before and on the day it is suspected …